1. Can HIV Infection be Prevented with a Vaccine?

   • Adele K. Joy
   • C. Jane Dale
   • Stephen J. Kent

   Section 1: HIV Vaccine 11 December 2012 Pages: 431 - 440

2. Prophylactic HIV Vaccines

   • Antona Wagstaff
   • Giles Brooke

   Section 1: HIV Vaccine 11 December 2012 Pages: 441 - 443

3. HIV gp120 vaccine (Chiron)

   Section 1: HIV Vaccine 11 December 2012 Pages: 445 - 447

4. HIV gp120 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern)

   Section 1: HIV Vaccine 11 December 2012 Pages: 448 - 448

5. HIV gp160 vaccine (Immuno AG)

   Section 1: HIV Vaccine 11 December 2012 Pages: 449 - 450

6. HIV gp160 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern)

   Section 1: HIV Vaccine 11 December 2012 Pages: 451 - 452

7. HIV HGP-30W vaccine (Cel-Sci)

   Section 1: HIV Vaccine 11 December 2012 Pages: 453 - 455

8. HIV vaccine AIDSVAX

   Section 1: HIV Vaccine 11 December 2012 Pages: 456 - 458

9. HIV vaccine vCP205

   Section 1: HIV Vaccine 11 December 2012 Pages: 459 - 460

10. Lipid-Altering Drugs in Development

    • Harold E. Bays
    • Carlos A. Dujovne

    Section 2: Lipid Disorder 11 December 2012 Pages: 463 - 469

11. Lipid Disorders

    • Stephen G. Coleman
    • Giles Brooke

    Section 2: Lipid Disorder 11 December 2012 Pages: 471 - 475

12. Avasimibe

    Section 2: Lipid Disorder 11 December 2012 Pages: 477 - 478

13. Colesevelam

    Section 2: Lipid Disorder 11 December 2012 Pages: 479 - 480

14. FCP 3P1

    Section 2: Lipid Disorder 11 December 2012 Pages: 481 - 482

15. Melatonin

    Section 2: Lipid Disorder 11 December 2012 Pages: 483 - 485

16. Nisvastatin

    Section 2: Lipid Disorder 11 December 2012 Pages: 486 - 487

17. NO 1886

    Section 2: Lipid Disorder 11 December 2012 Pages: 488 - 489

18. Pamaqueside

    Section 2: Lipid Disorder 11 December 2012 Pages: 490 - 490